What is the analyst consensus rating for BIIB?

The analyst consensus rating for BIIB is "Buy" based on 28 analyst recommendations.

What is the average price target for BIIB?

The average 12-month price target for BIIB is $211.35, representing an upside of 12.5% from the current price of $187.80.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Biogen Inc. (BIIB) Forecast: Analyst Ratings & Targets

Latest BIIB Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Apr 29, 2026	PerPlexity Drug Manufacturers - General	TipRanks - PerPlexity	Reiterates	Buy	$205.00 → $202.00 -3.00 (-1.5%)
Apr 28, 2026	Sumant Kulkarni	Canaccord Genuity	Reiterates	Buy	$245.00
Apr 27, 2026	Danielle Brill	Truist	Maintains	Hold	-
Apr 24, 2026	Salveen Richter	Goldman Sachs	Maintains	Buy	$231.00 → $238.00 +7.00 (3.0%)
Apr 24, 2026	Chris Schott	JP Morgan	Maintains	Hold	$175.00 → $185.00 +10.00 (5.7%)
Apr 22, 2026	Michael Yee	UBS	Upgrades	Strong Buy	$185.00 → $225.00 +40.00 (21.6%)
Apr 21, 2026	Emily Field	Barclays	Maintains	Hold	$185.00
Apr 20, 2026	Thomas Shrader	BTIG	Maintains	Hold	-
Apr 20, 2026	Mohit Bansal	Wells Fargo	Upgrades	Buy	$200.00 → $250.00 +50.00 (25.0%)
Apr 16, 2026	Yatin Suneja	Guggenheim	Reiterates	Buy	$246.00
Apr 14, 2026	David Amsellem	Piper Sandler	Upgrades	Buy	$177.00 → $214.00 +37.00 (20.9%)
Apr 14, 2026	Geoff Meacham	Citi	Initiates Coverage	Hold	$215.00 → $190.00 -25.00 (-11.6%)
Apr 13, 2026	Srikripa Devarakonda	Truist	Maintains	Hold	$193.00 → $189.00 -4.00 (-2.1%)
Apr 13, 2026	Geoff Meacham	Citi	Maintains	Hold	$215.00 → $190.00 -25.00 (-11.6%)
Apr 10, 2026	Matthew Harrison	Morgan Stanley	Maintains	Hold	$190.00 → $200.00 +10.00 (5.3%)
Apr 7, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Buy	-
Apr 7, 2026	Brian Abrahams	RBC Capital	Maintains	Buy	$233.00 → $213.00 -20.00 (-8.6%)
Apr 4, 2026	Paul Matteis	Stifel Nicolaus	Maintains	Buy	$187.57 → $214.00 +26.43 (14.1%)
Apr 2, 2026	Andrew S. Fein	HC Wainwright	Maintains	Strong Buy	$228.00 → $237.00 +9.00 (4.0%)
Apr 1, 2026	PerPlexity Drug Manufacturers - General	TipRanks - PerPlexity	Reiterates	Buy	$226.00 → $205.00 -21.00 (-9.3%)
Apr 1, 2026	Sumant Kulkarni	Canaccord Genuity	Maintains	Strong Buy	$230.00 → $245.00 +15.00 (6.5%)
Apr 1, 2026	Jay Olson	Oppenheimer	Maintains	Buy	$250.00 → $275.00 +25.00 (10.0%)
Mar 31, 2026	Thomas Shrader	BTIG	Maintains	Hold	-
Mar 31, 2026	Geoff Meacham	Citi	Maintains	Hold	$215.00
Mar 30, 2026	Myles Minter	William Blair	Reiterates	Buy	-
Mar 30, 2026	Phil Nadeau	TD Cowen	Reiterates	Buy	$215.00
Mar 30, 2026	Jason Zemansky	BofA Securities	Maintains	Hold	$207.00
Mar 30, 2026	Evan Seigerman	BMO Capital	Maintains	Hold	$196.00
Mar 30, 2026	Ami Fadia	Needham	Maintains	Hold	-
Mar 29, 2026	Michael Yee	UBS	Maintains	Hold	$185.00
Mar 29, 2026	Terence Flynn	Morgan Stanley	Maintains	Hold	$190.00
Mar 20, 2026	Salveen Richter	Goldman Sachs	Initiates Coverage	Buy	$225.00 → $231.00 +6.00 (2.7%)
Mar 17, 2026	Rajesh Kumar	HSBC	Maintains	Sell	$143.00 → $150.00 +7.00 (4.9%)
Mar 12, 2026	Andrew Tsai	Jefferies	Maintains	Buy	$210.00
Feb 26, 2026	Brian Abrahams	RBC Capital	Maintains	Buy	$233.00
Feb 23, 2026	Ilya Zubkov	Freedom Broker	Maintains	Hold	$160.00 → $185.00 +25.00 (15.6%)
Feb 20, 2026	Emily Field	Barclays	Initiates	Hold	$185.00

PerPlexity Drug Manufacturers - General

TipRanks - PerPlexity

BuyReiterates

$205.00 → $202.00

Apr 29

Sumant Kulkarni

Canaccord Genuity

BuyReiterates

$245.00

Apr 28

Danielle Brill

Truist

HoldMaintains

Apr 27

Salveen Richter

Goldman Sachs

BuyMaintains

$231.00 → $238.00

Apr 24

Chris Schott

JP Morgan

HoldMaintains

$175.00 → $185.00

Apr 24

Michael Yee

UBS

Strong BuyUpgrades

$185.00 → $225.00

Apr 22

Emily Field

Barclays

HoldMaintains

$185.00

Apr 21

Thomas Shrader

BTIG

HoldMaintains

Apr 20

Mohit Bansal

Wells Fargo

BuyUpgrades

$200.00 → $250.00

Apr 20

Yatin Suneja

Guggenheim

BuyReiterates

$246.00

Apr 16

David Amsellem

Piper Sandler

BuyUpgrades

$177.00 → $214.00

Apr 14

Geoff Meacham

Citi

HoldInitiates Coverage

$215.00 → $190.00

Apr 14

Srikripa Devarakonda

Truist

HoldMaintains

$193.00 → $189.00

Apr 13

Geoff Meacham

Citi

HoldMaintains

$215.00 → $190.00

Apr 13

Matthew Harrison

Morgan Stanley

HoldMaintains

$190.00 → $200.00

Apr 10

Zacks Equity Research

BuyInitiates Coverage

Apr 7

Brian Abrahams

RBC Capital

BuyMaintains

$233.00 → $213.00

Apr 7

Paul Matteis

Stifel Nicolaus

BuyMaintains

$187.57 → $214.00

Apr 4

Andrew S. Fein

HC Wainwright

Strong BuyMaintains

$228.00 → $237.00

Apr 2

PerPlexity Drug Manufacturers - General

TipRanks - PerPlexity

BuyReiterates

$226.00 → $205.00

Apr 1

Sumant Kulkarni

Canaccord Genuity

Strong BuyMaintains

$230.00 → $245.00

Apr 1

Jay Olson

Oppenheimer

BuyMaintains

$250.00 → $275.00

Apr 1

Thomas Shrader

BTIG

HoldMaintains

Mar 31

Geoff Meacham

Citi

HoldMaintains

$215.00

Mar 31

Myles Minter

William Blair

BuyReiterates

Mar 30

Phil Nadeau

TD Cowen

BuyReiterates

$215.00

Mar 30

Jason Zemansky

BofA Securities

HoldMaintains

$207.00

Mar 30

Evan Seigerman

BMO Capital

HoldMaintains

$196.00

Mar 30

Ami Fadia

Needham

HoldMaintains

Mar 30

Michael Yee

UBS

HoldMaintains

$185.00

Mar 29

Terence Flynn

Morgan Stanley

HoldMaintains

$190.00

Mar 29

Salveen Richter

Goldman Sachs

BuyInitiates Coverage

$225.00 → $231.00

Mar 20

Rajesh Kumar

HSBC

SellMaintains

$143.00 → $150.00

Mar 17

Andrew Tsai

Jefferies

BuyMaintains

$210.00

Mar 12

Brian Abrahams

RBC Capital

BuyMaintains

$233.00

Feb 26

Ilya Zubkov

Freedom Broker

HoldMaintains

$160.00 → $185.00

Feb 23

Emily Field

Barclays

HoldInitiates

$185.00

Feb 20

Biogen Inc. (BIIB) Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest BIIB Analyst Ratings & Recommendations

Frequently Asked Questions